Minimal Residual Disease (MRD) is one of the big topics in myeloma. Different techniques to measure MRD and new data about its role in predicting the risk of relapse are some of the topics discussed during the American Society of Hematology (ASH) Annual Meeting. In this video Dr Francesca Gay, University of Torino, Italy, explains …
By Finn Bo Petersen, Mohamad Mohty & 1 more. “the doctor kept looking into the computer screen on their desk during the whole consultation and…
We welcome you to join a special webinar for Practicing Hematologists on how to prevent burnout and cultivate satisfaction and fulfillment. In today’s practice of…
We welcome you to join a special webinar for Practicing Hematologists on how to prevent burnout and cultivate satisfaction and fulfillment. In today’s practice of…
By Mohamad Mohty, Kanti Rai. Dr Rai is the chief of Northwell Health’s CLL Research and Treatment Program. He is internationally recognized for his expertise…
We welcome you to join a special webinar for Practicing Hematologists on how to prevent burnout and cultivate satisfaction and fulfillment. In today’s practice of…
We welcome you to join a special webinar for Practicing Hematologists on how to prevent burnout and cultivate satisfaction and fulfillment. In today’s practice of…
IACH News of the Week IACH News of the Week, curated by Dr Edwin Uriel Suárez , is a weekly summary of the latest advancements…
We welcome you to join a special webinar for Practicing Hematologists on how to prevent burnout and cultivate satisfaction and fulfillment. In today’s practice of…
By Shakthi T Bhaskar, Bhagirathbhai Dholaria & 2 more. The Evolving Role of Bridging Therapy during CAR-T Therapy
